About Definiens
Definiens is a company based in Munchen (Germany) founded in 1994 was acquired by MedImmune in November 2014. Definiens has raised $33.25 million across 3 funding rounds from investors including European Union, MedImmune and TVM Capital Life Science. The company has 136 employees as of December 31, 2018. Definiens operates in a competitive market with competitors including PathAI, Viz.ai, Deepcell, Deciphex and Aignostics, among others.
- Headquarter Munchen, Germany
- Employees 136 as on 31 Dec, 2018
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$33.25 M (USD)
in 3 rounds
-
Latest Funding Round
$390.31 K (USD), Grant
Jan 05, 2015
-
Investors
European Union
& 5 more
-
Employee Count
136
as on Dec 31, 2018
-
Acquired by
MedImmune
(Nov 04, 2014)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Definiens
Definiens has successfully raised a total of $33.25M across 3 strategic funding rounds. The most recent funding activity was a Grant round of $390.31 thousand completed in January 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Definiens
Definiens has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include European Union, MedImmune and TVM Capital Life Science.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Capital is invested in life science innovations for healthcare transformation.
|
Locked | Locked | Locked | |
|
Investments are made in early-stage healthcare startups.
|
Locked | Locked | Locked | |
|
Private equity and venture captial firm focused on healthcare sectors
|
Locked | Locked | Locked |
Investor details for Definiens
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Definiens
Investment portfolio details for Definiens
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Definiens
Detailed financials for Definiens
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Definiens Comparisons
Peer comparison for Definiens
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Definiens
Definiens operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as PathAI, Viz.ai, Deepcell, Deciphex and Aignostics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of AI-based solutions for clinical diagnosis of cancer and other diseases
|
|
| Locked | Locked | Locked |
AI and cloud-powered software for stroke care coordination is developed.
|
|
| Locked | Locked | Locked |
AI-powered single cell classification and isolation technology for clinical research
|
|
| Locked | Locked | Locked |
Digital pathology software is developed for clinical and veterinary productivity.
|
|
| Locked | Locked | Locked |
AI-based pathology diagnostic software is provided for medical analysis.
|
|
| Locked | Locked | Locked |
AI-based tools for pathological image analysis are provided to labs.
|
Detailed competitors of Definiens
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Definiens
Complete news archive for Definiens
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Definiens
Definiens was founded in 1994 and raised its 1st funding round 18 years after it was founded.
Definiens is headquartered in Munchen, Germany. It is registered at Munchen, Bayern, Germany.
Definiens is a funded company, having raised a total of $33.25M across 3 funding rounds to date.
As of Dec 31, 2018, the latest employee count at Definiens is 136.
Provides image analysis and data mining solutions for quantitative digital pathology in the healthcare industry. It offers Tissue Studio, a solution for biomarker and morphological profiling in research and drug discovery on tissue samples; and Developer XD, a solution for scientists image analysis experts to create and validate automated solutions for a range of biomedical image analysis problems. The company also provides Image Miner, a solution that integrates data mining with image analysis to accelerate biomarker research and development in life sciences. In addition, it focuses on supporting discovery, research, and diagnostics development that rely on the analysis of tissue samples; provides solutions for various phases of drug development. Further, the company supports clients in various stages of clinical development that include assay development, clinical validation, and test commercialization.
Definiens's top competitors include Aignostics, Deciphex and Pictor Labs.
Definiens has 6 investors. Key investors include European Union, MedImmune, TVM Capital Life Science, Wellington Partners Venture Capital, and Cipio Partners.